We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLY
3526
DELISTED
Codorus Valley Bancorp Inc
CVLY
-28,092
Closed -$529K
COOL
3527
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
-1,161,738
Closed -$11.6M
ADTHW
3528
CALL
DELISTED
AdTheorent Holding Co Warrants
ADTHW
-70,000
Closed -$151K
TDCX
3529
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
-96,253
Closed -$903K
AONCW
3530
CALL
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-379,747
Closed -$3.73M
BREZW
3531
CALL
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
-239,308
Closed -$2.48M
ALPN
3532
DELISTED
Alpine Immune Sciences Inc
ALPN
-45,077
Closed -$323K
FHLT
3533
DELISTED
Future Health ESG Corp. Common stock
FHLT
-863,753
Closed -$8.65M
OSI
3534
DELISTED
Osiris Acquisition Corp.
OSI
-485,900
Closed -$4.76M
ZFOXW
3535
CALL
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
-50,549
Closed -$309K
PMGM
3536
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
-1,240,633
Closed -$12.4M
VAXX
3537
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
-178,258
Closed -$352K
CONX
3538
DELISTED
CONX Corp. Class A Common Stock
CONX
-3,618,769
Closed -$36.2M
NGMS
3539
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
-131,171
Closed -$1.69M
DCFCW
3540
CALL
DELISTED
Tritium DCFC Limited Warrant
DCFCW
-80,000
Closed -$255K
STIXW
3541
CALL
DELISTED
Semantix, Inc. Warrant
STIXW
-167,324
Closed -$432K
VIEW
3542
DELISTED
View, Inc. Class A Common Stock
VIEW
-176
Closed -$14K
VIEWW
3543
CALL
DELISTED
View, Inc. Warrant
VIEWW
-379,198
Closed -$509K
MBTC
3544
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
-22,522
Closed -$234K
LIAN
3545
DELISTED
LianBio American Depositary Shares
LIAN
-206,497
Closed -$410K
SPLK
3546
DELISTED
Splunk Inc
SPLK
-237,072
Closed -$17.8M
EAC
3547
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
-987,043
Closed -$9.76M
FAZEW
3548
CALL
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
-127,282
Closed -$1.23M
SAGA
3549
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
-45,537
Closed -$457K
BFX
3550
DELISTED
BowFlex Inc.
BFX
-126,668
Closed -$207K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.